IRS - Holbæk Sygehus

Medicin og biovidenskab

1. Meta-Analysis 100%
2. Systematic Reviews 99%
3. Randomized Controlled Trials 94%
4. Mortality 79%
5. Blood Pressure 65%
6. Type 2 Diabetes Mellitus 60%
7. Denmark 58%
8. Hypertension 55%
9. Cardiovascular Diseases 51%
10. Cohort Studies 50%
11. Hip Fractures 41%
12. Early Warning Score 41%
13. Osteoporosis 41%
14. Placebos 37%
15. Confidence Intervals 37%
16. Nurses 35%
17. Population 33%
18. Therapeutics 32%
19. Nepal 32%
20. Heart Failure 28%
21. Biomarkers 27%
22. Atrial Fibrillation 26%
23. Quality of Life 25%
24. Critical Illness 25%
25. Delirium 25%
26. Registries 25%
27. Odds Ratio 24%
28. Critical Care 24%
29. Urokinase Plasminogen Activator Receptors 22%
30. Cardiac Rehabilitation 22%
31. Diphosphonates 21%
32. Coronary Artery Disease 21%
33. Guidelines 20%
34. Osteoporotic Fractures 20%
35. Health 20%
36. Morbidity 20%
37. Intensive Care Units 20%
38. Galectin 4 20%
39. Clinical Trials 18%
40. Myocardial Ischemia 18%
41. Coronary Disease 17%
42. Patient Care 17%
43. Aortic Valve Stenosis 17%
44. Databases 16%
45. Polycystic Ovary Syndrome 16%
46. Brain Natriuretic Peptide 15%
47. Exercise 15%
48. Pharmaceutical Preparations 15%
49. Risk Assessment 15%
50. Myocardial Infarction 15%
51. Bone Density 14%
52. Pain 14%
53. Data Analysis 14%
54. Osteogenesis Imperfecta 14%
55. Prospective Studies 14%
56. Life Style 14%
57. Glucose 14%
58. Multicenter Studies 14%
59. Stroke 13%
60. Chronic Hepatitis B 13%
61. Out-of-Hospital Cardiac Arrest 13%
62. Hip 13%
63. Ibuprofen 13%
64. Vitamin D 13%
65. Coronary Vessels 13%
66. Acetaminophen 13%
67. Antihypertensive Agents 13%
68. Telemedicine 13%
69. Observational Studies 12%
70. Child 12%
71. Serum 12%
72. Mentoring 12%
73. Sepsis 12%
74. Interviews 12%
75. Hypothermia 12%
76. Norway 12%
77. Proton Pump Inhibitors 12%
78. Glucose Tolerance Test 12%
79. Obesity 11%
80. Elderly 11%
81. Overweight 11%
82. Bone and Bones 11%
83. Pediatric Obesity 11%
84. Hepatitis B 11%
85. Cardiology 11%
86. Ezetimibe 11%
87. Incidence 11%
88. Inflammation 11%
89. C-Reactive Protein 11%
90. Left Ventricular Hypertrophy 11%
91. Induced Hypothermia 11%
92. Ivabradine 10%
93. Body Mass Index 10%
94. Clavicle 10%
95. Safety 10%
96. MEDLINE 10%
97. Clarithromycin 10%
98. Carbohydrate-Restricted Diet 10%
99. Research Personnel 10%
100. Denosumab 10%